Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Inflammatory Bowel Diseases

Free Subscription 17.11.2025 3 Aliment Pharmacol Ther 1 Clin Gastroenterol Hepatol 3 Dig Dis Sci 1 Dis Colon Rectum 5 Inflamm Bowel Dis 4 J Crohns Colitis 1 J Gastroenterol 2 Mediators Inflamm 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. BAILLIE S, Blackwell J, Pollok R
   Letter: From Descriptive Epidemiology to Clinical Imperative-Challenging the Paradigm of Pain and Sedative Use in Inflammatory Bowel Disease. Authors' Reply.
   Aliment Pharmacol Ther. 2025 Nov 12. doi: 10.1111/apt.70459.
   PubMed        
   
   
2. YANG D, Yang J, Wang S, Wang G, et al
   Letter: From Descriptive Epidemiology to Clinical Imperative-Challenging the Paradigm of Pain and Sedative Use in Inflammatory Bowel Disease.
   Aliment Pharmacol Ther. 2025 Nov 12. doi: 10.1111/apt.70416.
   PubMed        
   
   
3. MURTHY SK, Ahmed F, Pugliese M, Taljaard M, et al
   A Population-Based Matched Cohort Study of Extra-Digestive Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease.
   Aliment Pharmacol Ther. 2025 Nov 11. doi: 10.1111/apt.70439.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

4. KAYAL M, Jimenez D, Huang J, Spencer EA, et al
   Comparable 12-Week and Superior 24-Week Remission with Risankizumab vs Ustekinumab for Crohn's-Like Disease of the Pouch.
   Clin Gastroenterol Hepatol. 2025 Nov 7:S1542-3565(25)00935.
   PubMed        
   
   

   
   Dig Dis Sci

5. ABUBASHEER TM, Saad K, Altaweel A, Alomari O, et al
   Systematic Review of Bile Acids Metabolism in Crohn's Disease: Implications for Pathogenesis and Therapeutic Interventions.
   Dig Dis Sci. 2025 Nov 12. doi: 10.1007/s10620-025-09557.
   PubMed         Abstract available
   
   
6. MEDAWAR E, Chin Koon Siw K, Zoughlami A, Ekhdoura M, et al
   Fistula Outcomes After Seton Removal in Patients with Perianal Fistulizing Crohn's Disease: A Systematic Review and Meta-Analysis.
   Dig Dis Sci. 2025 Nov 11. doi: 10.1007/s10620-025-09555.
   PubMed         Abstract available
   
   
7. SAHYOUN LC, Gaidos JKJ
   Weighing In: The Use of Glucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease.
   Dig Dis Sci. 2025 Nov 11. doi: 10.1007/s10620-025-09515.
   PubMed        
   
   

   
   Dis Colon Rectum

8. VAN RENTERGHEM ARPKM, van der Holst AM, van Kuijk S, Belgers E, et al
   Recurrence After Ileocolic Resection for Crohn's Disease: Further Unravelling the Search for Risk Factors.
   Dis Colon Rectum. 2025 Nov 11. doi: 10.1097/DCR.0000000000004014.
   PubMed         Abstract available
   
   

   
   Inflamm Bowel Dis

9. ANJIE SI, D'Haens GR, Baert F, Bossuyt P, et al
   Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease.
   Inflamm Bowel Dis. 2025 Nov 10:izaf255. doi: 10.1093.
   PubMed        
   
   
10. QURAISHI MN, Ahmad MA, Ali NA, Church RD, et al
    Initial Management of Intra-Abdominal Abscess in Crohn's Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2025 Nov 10:izaf242. doi: 10.1093.
    PubMed         Abstract available
    
    
11. RUBIN DT, Reinisch W, Narula N, Colucci DR, et al
    Machine Learning Models for the Assessment of the Mayo Endoscopic Score in Ulcerative Colitis Trial Endpoints: A Systematic Review.
    Inflamm Bowel Dis. 2025 Nov 4:izaf232. doi: 10.1093.
    PubMed         Abstract available
    
    
12. KELLAR A, George T, Dolinger MT, Smyth M, et al
    Reliability and Validity of Mesenteric Fat Assessment by Intestinal Ultrasound in Pediatric Crohn's Disease Using the Chicago Mesenteric Fat Index.
    Inflamm Bowel Dis. 2025 Nov 6:izaf238. doi: 10.1093.
    PubMed         Abstract available
    
    
13. YANG X, Yang S
    Comment on "The Severity of Rectal Inflammation and Pouch Surgery Outcome in Patients with Ulcerative Colitis: A Retrospective Cohort Study".
    Inflamm Bowel Dis. 2025 Nov 6:izaf253. doi: 10.1093.
    PubMed        
    
    

    
    J Crohns Colitis

14. WONG ECL, Marshall JK, Ma C, Jairath V, et al
    Addition of Baseline Histology and Fecal Calprotectin Does Not Reduce Placebo Rates in Ulcerative Colitis Clinical Trials: Post-hoc Analysis of Patient Level Data.
    J Crohns Colitis. 2025 Nov 9:jjaf194. doi: 10.1093.
    PubMed         Abstract available
    
    
15. SOLITANO V, Hogan M, Singh S, Danese S, et al
    Placebo rates in randomised clinical trials of ulcerative colitis: An individual patient data meta-analysis.
    J Crohns Colitis. 2025 Nov 9:jjaf191. doi: 10.1093.
    PubMed         Abstract available
    
    
16. HYON SS, Elsawwah JK, Shaikh FA, Flanagan JS, et al
    Comparison of Early Ileocolic Resection and Medical Treatment for Crohn's Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2025 Nov 9:jjaf190. doi: 10.1093.
    PubMed         Abstract available
    
    
17. MOREIRA PL, Dignass A, Estevinho MM, Santiago M, et al
    Establishing a multiple outcome set for Crohn's disease in real-world evidence studies: results from a Delphi e-survey.
    J Crohns Colitis. 2025;19:jjaf178.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

18. NISAR M, Awan AR, Ahmad A, Saleem H, et al
    Diagnostic accuracy of anti-integrin alphavbeta6 in ulcerative colitis: a diagnostic meta-analysis.
    J Gastroenterol. 2025 Nov 13. doi: 10.1007/s00535-025-02319.
    PubMed         Abstract available
    
    

    
    Mediators Inflamm

19. LI H, Tang D, Liu Y, Li Q, et al
    A Multitrait Analysis of Genome-Wide Association Study Reveals the Shared Genetic Architecture Between Inflammatory Bowel Disease and Ankylosing Spondylitis.
    Mediators Inflamm. 2025;2025:4012195.
    PubMed         Abstract available
    
    
20. SENYUZ B, Unal NG, Yakut BD, Uzel A, et al
    Influence of Fusobacterium nucleatum on Tumor Necrosis Factor Alpha Therapy in Ulcerative Colitis.
    Mediators Inflamm. 2025;2025:5035877.
    PubMed         Abstract available
    
    

    
    PLoS One

21. LIU M, Ge J, Guo L, Wu Z, et al
    Integrative machine learning and multi-omics framework identifies shared biomarkers for rheumatoid arthritis and ulcerative colitis.
    PLoS One. 2025;20:e0336243.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

22. JI M, Liang H, Dong S, Guo Y, et al
    The SWI/SNF chromatin-remodeling subunit DPF2 regulates macrophage inflammation in intestinal injury via the CACNA1D-mediated MAPK pathway.
    Proc Natl Acad Sci U S A. 2025;122:e2518762122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.